278 related articles for article (PubMed ID: 27927647)
1. GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
Bunting MD; Varelias A; Souza-Fonseca-Guimaraes F; Schuster IS; Lineburg KE; Kuns RD; Fleming P; Locke KR; Huntington ND; Blazar BR; Lane SW; Tey SK; MacDonald KP; Smyth MJ; Degli-Esposti MA; Hill GR
Blood; 2017 Feb; 129(5):630-642. PubMed ID: 27927647
[TBL] [Abstract][Full Text] [Related]
2. Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice.
Wikstrom ME; Fleming P; Kuns RD; Schuster IS; Voigt V; Miller G; Clouston AD; Tey SK; Andoniou CE; Hill GR; Degli-Esposti MA
Blood; 2015 Sep; 126(12):1503-14. PubMed ID: 26130706
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
[TBL] [Abstract][Full Text] [Related]
4. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
5. Quantity and Quality Reconstitution of NKG2A
Hu LJ; Zhao XY; Yu XX; Lv M; Han TT; Han W; Huang XJ
Biol Blood Marrow Transplant; 2019 Jan; 25(1):1-11. PubMed ID: 30142416
[TBL] [Abstract][Full Text] [Related]
6. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.
Olson JA; Leveson-Gower DB; Gill S; Baker J; Beilhack A; Negrin RS
Blood; 2010 May; 115(21):4293-301. PubMed ID: 20233969
[TBL] [Abstract][Full Text] [Related]
7. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
[TBL] [Abstract][Full Text] [Related]
8. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
9. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
10. The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.
Yang YG; Sykes M
Leuk Lymphoma; 1999 May; 33(5-6):409-20. PubMed ID: 10342569
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
12. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
[TBL] [Abstract][Full Text] [Related]
14. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation.
Jiang YZ; Barrett AJ; Goldman JM; Mavroudis DA
Ann Hematol; 1997 Jan; 74(1):1-6. PubMed ID: 9031607
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
17. S1PR5 regulates NK cell responses in preventing graft-versus-host disease while preserving graft-versus-tumour activity in a murine allogeneic haematopoietic stem cell transplantation model.
Wang F; Zhao S; Gu Z; Zhao X; Yang N; Guan L; Liu T; Wang L; Fang S; Zhu C; Luo L; Li M; Wang L; Gao C
Hematol Oncol; 2020 Feb; 38(1):89-102. PubMed ID: 31465552
[TBL] [Abstract][Full Text] [Related]
18. IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation.
Song Y; Hu B; Liu Y; Jin Z; Zhang Y; Lin D; Zhu Y; Lei L; Gong H; Mei Y; Teo HY; Wu D; Liu H
Eur J Immunol; 2018 Apr; 48(4):670-682. PubMed ID: 29282719
[TBL] [Abstract][Full Text] [Related]
19. Donor Lymphocyte-Derived Natural Killer Cells Control MHC Class I-Negative Melanoma.
Dang N; Lin Y; Waer M; Sprangers B
Cancer Immunol Res; 2020 Jun; 8(6):756-768. PubMed ID: 32209636
[TBL] [Abstract][Full Text] [Related]
20. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.
Murphy WJ; Longo DL
Immunol Rev; 1997 Jun; 157():167-76. PubMed ID: 9255629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
